As I step into Rajeev Juneja’s office at Mankind Pharma’s Delhi headquarters, the wall in front of me immediately commands attention. It features a collection of iconic quotes and striking ...

Besides Mankind, Natco Pharma, Dr Reddy’s, Sun Pharma and others are already gearing up for launches of weight-loss drugs like Ozempic and Wegovy, which are going off patent in India in January 2026 ...

In July 2024, Mankind Pharma entered into a definitive agreementto acquire 100% of Bharat Serums and Vaccines (BSV) from private equity investor Advent International for an enterprise value of ...

We have seen very promising Phase 1 results and have recently started Phase 2 trials in Australia,” said Arjun Juneja, COO, Mankind Pharma. “The results are expected by the end of this year.